- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Randomised controlled trial, Single centre
- Objective: To estimate the effect of ibuzatrelvir on the PK of dabigatran, a P-gp substrate, in healthy adult participants
- Number of participants enrolled: 20
- Study enrolling from to
- Study includes follow-up for 35 days
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Ibuzatrelvir
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to